Free Trial

Koninklijke Philips N.V. $PHG Shares Acquired by Charles Schwab Investment Management Inc.

Koninklijke Philips logo with Medical background

Key Points

  • Charles Schwab Investment Management Inc. increased its stake in Koninklijke Philips N.V. by 18.0% in the first quarter, holding a total of 72,276 shares valued at approximately $1.84 million.
  • Other institutional investors have also boosted their positions, with Northern Trust Corp raising its stake by 36.6% and GAMMA Investing LLC increasing theirs by a staggering 3,094.8%.
  • In its recent earnings report, Koninklijke Philips reported $0.41 EPS, beating estimates of $0.29, and had a revenue of $5.05 billion compared to a forecast of $4.35 billion.
  • MarketBeat previews the top five stocks to own by October 1st.

Charles Schwab Investment Management Inc. raised its position in Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 18.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,276 shares of the technology company's stock after purchasing an additional 11,018 shares during the quarter. Charles Schwab Investment Management Inc.'s holdings in Koninklijke Philips were worth $1,836,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Intrust Bank NA increased its stake in shares of Koninklijke Philips by 13.4% in the first quarter. Intrust Bank NA now owns 18,656 shares of the technology company's stock valued at $474,000 after purchasing an additional 2,202 shares during the period. ABC Arbitrage SA increased its stake in shares of Koninklijke Philips by 183.9% in the first quarter. ABC Arbitrage SA now owns 101,108 shares of the technology company's stock valued at $2,568,000 after purchasing an additional 65,490 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of Koninklijke Philips by 28.0% in the first quarter. PNC Financial Services Group Inc. now owns 45,442 shares of the technology company's stock valued at $1,154,000 after purchasing an additional 9,934 shares during the period. US Bancorp DE increased its stake in shares of Koninklijke Philips by 0.9% in the first quarter. US Bancorp DE now owns 109,831 shares of the technology company's stock valued at $2,790,000 after purchasing an additional 1,014 shares during the period. Finally, Nicolet Advisory Services LLC increased its stake in shares of Koninklijke Philips by 14.5% in the first quarter. Nicolet Advisory Services LLC now owns 10,480 shares of the technology company's stock valued at $266,000 after purchasing an additional 1,328 shares during the period. Institutional investors and hedge funds own 13.67% of the company's stock.

Koninklijke Philips Price Performance

Shares of Koninklijke Philips stock traded up $0.20 on Friday, hitting $27.93. The company had a trading volume of 609,087 shares, compared to its average volume of 699,129. The business has a 50-day simple moving average of $26.13 and a 200-day simple moving average of $25.00. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.26 and a quick ratio of 0.81. The company has a market cap of $26.89 billion, a PE ratio of 146.97, a PEG ratio of 0.75 and a beta of 0.81. Koninklijke Philips N.V. has a 52 week low of $21.48 and a 52 week high of $32.91.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.12. The business had revenue of $5.05 billion during the quarter, compared to analysts' expectations of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. Research analysts expect that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Buy".

Get Our Latest Report on PHG

Koninklijke Philips Profile

(Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

See Also

Institutional Ownership by Quarter for Koninklijke Philips (NYSE:PHG)

Should You Invest $1,000 in Koninklijke Philips Right Now?

Before you consider Koninklijke Philips, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.

While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.